Margarita Véjar

Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

Kausik K Ray, Helen M Colhoun, Michael Szarek et al. · The Lancet Diabetes & Endocrinology · 2019 · 328 citations · Full text

Medicine, Cardiology, Internal Medicine +15

Spontaneous coronary artery spasm in variant angina is caused by a local hyperreactivity to a generalized constrictor stimulus

Juan Carlos Kaski, Attilio Maseri, Margarita Véjar et al. · Journal of the American College of Cardiology · 1989 · 133 citations

Medicine, Cardiology, Physiology +4

Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab

Emil Hagström, Philippe Gabríel Steg, Michael Szarek et al. · Circulation · 2022 · 122 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Dissociation of Platelet Activation and Spontaneous Myocardial Ischemia in Unstable Angina

Margarita Véjar, Gabriele Fragasso, David Hackett et al. · Thrombosis and Haemostasis · 1990 · 118 citations

Medicine, Cardiology, Pharmacology +17

Effect of SGLT2 Inhibitors on Stroke and Atrial Fibrillation in Diabetic Kidney Disease

Zien Zhou, Meg Jardine, Qiang Li et al. · Stroke · 2021 · 118 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17